Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing
Chronic Wound Treatment With Extracellular Matrix (ECM) Scaffold Made From Fish Proteins
2 other identifiers
interventional
37
1 country
1
Brief Summary
The clinical study is designed to assess the effectiveness, safety and non-immunogenicity of fish skin wound dressing extracellular matrix (ECM) in treating chronic wounds. The wound dressing is indicated for the management of difficult to heal and chronic wounds. The matrix is cut to fit the wound and is applied to the wound bed. An absorptive secondary dressing is put on top. Further dressing of the wound depends on the etiology. The indications for use are:
- partial and full-thickness wounds
- pressure ulcers
- venous ulcers
- diabetic ulcers
- chronic vascular ulcers
- tunneled/undermined wounds
- trauma wounds (abrasions, lacerations, second-degree burns, and skin tears)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 4, 2011
CompletedFirst Posted
Study publicly available on registry
May 5, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedMarch 3, 2017
May 1, 2011
2.1 years
May 4, 2011
February 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wound healing
one year
Secondary Outcomes (1)
Wound granulation
one year
Study Arms (1)
Marigen Wound Dressing
EXPERIMENTALInterventions
The dressing is changed at least twice a week, with no more than five days between dressing changes. It is extremely important that the dressings are changed sufficiently often. On highly exuding ulcers the three or four dressing changes per week may be necessary. Duration is four weeks.
Eligibility Criteria
You may qualify if:
- Venous leg ulcer
- Arterial leg ulcer
- Rheumatic leg ulcer
- Hydrostatic leg ulcer
- Ulcer where healing is delayed because of drug therapy
- Non-healing ulcer due to known or unknown causes
You may not qualify if:
- Active infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kerecis Ltd.lead
Study Sites (1)
National University Hospital
Reykjavik, 108, Iceland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2011
First Posted
May 5, 2011
Study Start
November 1, 2010
Primary Completion
December 1, 2012
Study Completion
January 1, 2013
Last Updated
March 3, 2017
Record last verified: 2011-05